Found: 28
Select item for more details and to access through your institution.
Glycan‐masking hemagglutinin antigens from stable CHO cell clones for H5N1 avian influenza vaccine development.
- Published in:
- Biotechnology & Bioengineering, 2019, v. 116, n. 3, p. 598, doi. 10.1002/bit.26810
- By:
- Publication type:
- Article
Development of single-chain variable fragments (scFv) against influenza virus targeting hemagglutinin subunit 2 (HA2).
- Published in:
- Archives of Virology, 2016, v. 161, n. 1, p. 19, doi. 10.1007/s00705-015-2625-6
- By:
- Publication type:
- Article
Type IIb Heat Labile Enterotoxin B Subunit as a Mucosal Adjuvant to Enhance Protective Immunity against H5N1 Avian Influenza Viruses.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 710, doi. 10.3390/vaccines8040710
- By:
- Publication type:
- Article
Use of PELC/CpG Adjuvant for Intranasal Immunization with Recombinant Hemagglutinin to Develop H7N9 Mucosal Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 240, doi. 10.3390/vaccines8020240
- By:
- Publication type:
- Article
Highly Pathogenic Avian Influenza H5 Hemagglutinin Fused with the A Subunit of Type IIb Escherichia coli Heat Labile Enterotoxin Elicited Protective Immunity and Neutralization by Intranasal Immunization in Mouse and Chicken Models.
- Published in:
- Vaccines, 2019, v. 7, n. 4, p. 193, doi. 10.3390/vaccines7040193
- By:
- Publication type:
- Article
Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 4902, doi. 10.3390/ijms23094902
- By:
- Publication type:
- Article
Production of Retrovirus and Adenovirus Vectors for Gene Therapy: A Comparative Study Using Microcarrier and Stationary Cell Culture.
- Published in:
- Biotechnology Progress, 2002, v. 18, n. 3, p. 617, doi. 10.1021/bp020026p
- By:
- Publication type:
- Article
Stationary and Microcarrier Cell Culture Processes for Propagating Japanese Encephalitis Virus.
- Published in:
- Biotechnology Progress, 2002, v. 18, n. 1, p. 124, doi. 10.1021/bp010120q
- By:
- Publication type:
- Article
Increase of Primary HIV-1 Production in Human Peripheral Blood Mononuclear Cells by Intermittent Medium Replenishment.
- Published in:
- Biotechnology Progress, 1998, v. 14, n. 3, p. 540, doi. 10.1021/bp980020t
- By:
- Publication type:
- Article
Heterologous Protein Expression Affects the Death Kinetics of Baculovirus-Infected Insect Cell Cultures: A Quantitative Study by Use of n-Target Theory.
- Published in:
- Biotechnology Progress, 1994, v. 10, n. 1, p. 55, doi. 10.1021/bp00025a006
- By:
- Publication type:
- Article
Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein.
- Published in:
- Biopolymers, 2010, v. 94, n. 3, p. 331, doi. 10.1002/bip.21371
- By:
- Publication type:
- Article
Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0106756
- By:
- Publication type:
- Article
Dengue Type Four Viruses with E-Glu<sub>345</sub>Lys Adaptive Mutation from MRC-5 Cells Induce Low Viremia but Elicit Potent Neutralizing Antibodies in Rhesus Monkeys.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0100130
- By:
- Publication type:
- Article
Glycan Masking of Hemagglutinin for Adenovirus Vector and Recombinant Protein Immunizations Elicits Broadly Neutralizing Antibodies against H5N1 Avian Influenza Viruses.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092822
- By:
- Publication type:
- Article
Different Immunity Elicited by Recombinant H5N1 Hemagglutinin Proteins Containing Pauci-Mannose, High-Mannose, or Complex Type N-Glycans.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066719
- By:
- Publication type:
- Article
Co‐delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1‐dominant humoral and cellular immunity against SARS‐CoV‐2.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 8, p. 1, doi. 10.1002/jmv.29040
- By:
- Publication type:
- Article
Progress and Concept for COVID‐19 Vaccine Development.
- Published in:
- Biotechnology Journal, 2020, v. 15, n. 6, p. 1, doi. 10.1002/biot.202000147
- By:
- Publication type:
- Article
Heterologous prime-boost immunization regimens using adenovirus vector and virus-like particles induce broadly neutralizing antibodies against H5N1 avian influenza viruses.
- Published in:
- Biotechnology Journal, 2013, v. 8, n. 11, p. 1315, doi. 10.1002/biot.201300116
- By:
- Publication type:
- Article
Kinetic characterization of baculovirus-induced cell death in insect cell cultures.
- Published in:
- Biotechnology & Bioengineering, 1993, v. 41, n. 1, p. 104, doi. 10.1002/bit.260410114
- By:
- Publication type:
- Article
Identification of Immunoreactive Peptides of Toxins to Simultaneously Assess the Neutralization Potency of Antivenoms against Neurotoxicity and Cytotoxicity of Naja atra Venom.
- Published in:
- Toxins, 2018, v. 10, n. 1, p. 10, doi. 10.3390/toxins10010010
- By:
- Publication type:
- Article
In silico prediction of immune-escaping hot spots for future COVID-19 vaccine design.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40741-1
- By:
- Publication type:
- Article
In silico prediction of immune-escaping hot spots for future COVID-19 vaccine design.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40741-1
- By:
- Publication type:
- Article
Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.795741
- By:
- Publication type:
- Article
Site-Specific Glycan-Masking/Unmasking Hemagglutinin Antigen Design to Elicit Broadly Neutralizing and Stem-Binding Antibodies Against Highly Pathogenic Avian Influenza H5N1 Virus Infections.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.692700
- By:
- Publication type:
- Article
Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 5, p. 1014, doi. 10.3390/pharmaceutics14051014
- By:
- Publication type:
- Article
Polymeric Caffeic Acid Acts as a Nasal Vaccine Formulation against Streptococcus pneumoniae Infections in Mice.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 585, doi. 10.3390/pharmaceutics13040585
- By:
- Publication type:
- Article
Neuraminidase (NA) 370-Loop Mutations of the 2009 Pandemic H1N1 Viruses Affect NA Enzyme Activity, Hemagglutination Titer, Mouse Virulence, and Inactivated-Virus Immunogenicity.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 6, p. N.PAG, doi. 10.3390/v14061304
- By:
- Publication type:
- Article
Selection and Characterization of DNA Aptamers Targeting All Four Serotypes of Dengue Viruses.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0131240
- By:
- Publication type:
- Article